MicroConstants is a GLP-compliant Contract Research Organization focused on performing bioanalysis, drug metabolism, and pharmacokinetic analysis in support of new therapeutic development programs. We specialize in method development, validation, and sample analysis for small molecules and macromolecules using LC/MS/MS, HPLC/UV, and immunoassay techniques.
Poster Presentation at WRIB
Our scientists recently presented a poster on Validated Multi-site GLP-compliant Analysis of Solithromycin (SOLI) in Monkey Plasma Samples Following Filtration to Remove Potentially Active Anthrax Spores
at the Workshop on Recent Issues in Bioanalysis (WRIB).View this poster
AA98 Antibody Development Rights
MicroConstants China has signed a licensing agreement to gain the global rights for the development of AA98 antibody drug candidates for the treatment of various cancers, multiple sclerosis (MS), and age related macular degeneration (AMD) from the Institute of Biophysics
(IBP), Chinese Academy of Sciences (CAS).Read more about AA98
Boston PBSS Workshop